COP vs DHR: Which Is the Better Buy?
Side-by-side comparison of ConocoPhillips and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
ConocoPhillips · Energy
$108.44
-21.6% upside to fair value
Grade D
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
COP trades at a lower forward P/E
(18.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COP |
DHR |
| Current Price |
$108.44 |
$195.98 |
| Fair Value Estimate |
$85.04 |
$211.54 |
| Upside to Fair Value |
-21.6%
|
+7.9%
|
| Market Cap |
$132.1B |
$138.7B |
| Forward P/E |
18.4x
|
37.8x
|
| EV / EBITDA |
6.1x
|
22.8x
|
| Price / Sales |
2.3x
|
5.6x
|
| Price / FCF |
8.6x
|
26.2x
|
| Revenue Growth YoY |
-2.5%
|
+3.7%
|
| Gross Margin |
29.2%
|
60.7%
|
| Operating Margin |
18.3%
|
21.0%
|
| Return on Equity |
11.3%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
11.64%
|
3.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
ConocoPhillips is a major player in the Energy sector focused on Oil & Gas Exploration & Production. The company demonstrates medium business quality with a stable competitive position but faces earnings pressure as reflected in a 23.4% decline in earnings and a 2.5% decline in revenue in the most recent quarter year-over-year. Despite a solid ROE of 11.3% and attractive margins (gross margin 29.…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
COP |
DHR |
| Zone Low |
$63.78 |
$158.66 |
| Zone High |
$72.28 |
$179.81 |
| In Buy Zone? |
No
|
No
|